Hepatitis: all 3,372 studies
Page 16 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Micro-elimination of Hepatitis C Virus Infection in UremicsStatus unknownNCT03891550Phase 3
- Simplifying HCV Treatment in Rwanda for Elsewhere in the Developing World: Pangenotypic and Retreatment Study (SHARED3)Status unknownNCT03888729Phase 4
- Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)Status unknownNCT03887637
- Safety of Sofosbuvir in People With Advanced Kidney FailureCompletedNCT03883698Phase 3
- Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients SeraStatus unknownNCT03882307Early Phase 1
- Direct Acting Antivirals for HCV Infection in Kidney Transplant RecipientsCompletedNCT03880682
- Conquering Hepatitis C Via Micro-Elimination in Southwest VirginiaStatus unknownNCT03876470
- Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian FederationCompletedNCT03868163
- Hepatitis B Virus Infection in Immunized Children With HBsAg-positive ParentsStatus unknownNCT03864263
- Trial of Antibody Responses by Vitamin SupplementationTerminatedNCT03859687Phase 1
- Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected PatientsCompletedNCT03855176Phase 4
- Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV InfectionStatus unknownNCT03854630Phase 4
- HCV Viral Hepatitis, Blood Sugar Level and Systolic Blood Pressure in EgyptCompletedNCT03839979
- Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Treatment With Pegylated Interferon/Ribavirin Patients With Chronic Hepatitis C Genotype 1 (PIONEER - Study)CompletedNCT03833362Phase 3
- Tool to Improve Treatment Adherence and Outcomes at Grady Liver ClinicCompletedNCT03831555Not applicable
- Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in SenegalWithdrawnNCT03829735Not applicable
- Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis- Assessment of Impact on Prognosis and Short-term OutcomeStatus unknownNCT03827772Not applicable
- Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/VelpatasvirCompletedNCT03818308Phase 2
- Hepatitis C Patient Management and Family Health EducationStatus unknownNCT03813498Not applicable
- Motivational Interviewing for HCV EliminationTerminatedNCT03804814Not applicable
- The Incidence of Hepatitis B in Diffuse Large B-Cell Lymphoma/Chronic Lymphoid Leukemia HBsAg-positive Treated With Rituximab, Chemotherapy and Tenofovir AlafenamideTerminatedNCT03804372Phase 2
- A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B PatientsStatus unknownNCT03801798Phase 2
- The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAgStatus unknownNCT03801538Phase 4
- TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)Status unknownNCT03798119Phase 4
- ATTIC - Access To Treat in the CommunityTerminatedNCT03797066Phase 4
- A Comprehensive HBsAg-positive Patients Centered Screening StrategyCompletedNCT03794791
- A Prospective Cohort Study to Improve HCV Care in Dialysis PatientsWithdrawnNCT03791814Phase 4
- Renoprotective Effects of Telbivudine in Chronic Hepatitis BCompletedNCT03778567Phase 4
- Prediction System of Clinical Endpoint Events for Chronic Hepatitis B PatientsActive, not recruitingNCT03777969
- Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to EliminationStatus unknownNCT03776760
- Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.Status unknownNCT03775798
- Study of Safety and Tolerability of DCR HBVSCompletedNCT03772249Phase 1
- Hepatitis C Surveillance With Linkage to Care of Patients From Non-ID Departments in JiangsuStatus unknownNCT03772002Not applicable
- A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINAStatus unknownNCT03770624Phase 1
- Ribavirin to Enhance Hepatitis B Virus Nucleotide Analog Antiviral ActivityStatus unknownNCT03759782Phase 3
- Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current GuidelinesActive, not recruitingNCT03753074Phase 4
- TAF Real World Study for Universal EffectivenessStatus unknownNCT03752658
- Treatment of Egyptian Hepatitis C Genotype 4 Infected Children and Adolescents With Combined Ledipasvir/SofosbuvirStatus unknownNCT03743727Phase 4
- Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison SettingCompletedNCT03740906
- Evaluation of Antiviral Indications on Chronic HBV Infection With Different Transaminase LevelsStatus unknownNCT03740789
- An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New DrugsCompletedNCT03740230
- IL-35+Breg/Il-35 Effect on T Cell Immune in Patients With CHBCompletedNCT03734783
- Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT03733652Not applicable
- Effect of Omega 5 Fatty Acid as an Adyuvant Treatment to Prednisone in Patients With Severe Alcoholic HepatitisCompletedNCT03732586Not applicable
- Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney TransplantationTerminatedNCT03723824Phase 4
- Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2aCompletedNCT03719313Phase 3
- A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis BCompletedNCT03714152Phase 1
- Behavioral Science and Hepatitis C Screening OutreachCompletedNCT03712553Not applicable
- Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune HepatitisStatus unknownNCT03711669
- STOP HCC: Mailed HCV Treatment Outreach Program for HCC PreventionCompletedNCT03706742Not applicable
- GCSF in Alcoholic HepatitisStatus unknownNCT03703674Phase 4
- Hepatocellular Carcinoma in HIV-infected Individuals in Asian PopulationCompletedNCT03702998
- Hepatitis C Positive Donor Into Hepatitis C Negative RecipientsWithdrawnNCT03702218Early Phase 1
- Ask a Friend to Take a Test for Hepatitis C InfectionCompletedNCT03697135
- Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B VirusStatus unknownNCT03695029Phase 4
- Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for VasculitisCompletedNCT03693586
- An Observational Study of Patients With Chronic Hepatitis B (CHB) InfectionTerminatedNCT03692897
- Class II Invariant Chain HCV Vaccine StudyCompletedNCT03688061Phase 1
- Oral Microbiome of Patients With Hepatitis C Virus InfectionCompletedNCT03682549
- The Norwegian Nucleoside Analogue Stop StudyCompletedNCT03681132Phase 4
- Clinical Pharmacokinetics of TKIs in Chinese Patients of Hepatitis B (HBV)Status unknownNCT03680183
- Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus InfectionCompletedNCT03674125Phase 1
- The Sublimated Mare Milk Supplement in Hepatitis CCompletedNCT03669835Not applicable
- To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)CompletedNCT03654677Phase 3
- To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A VaccineCompletedNCT03654664Phase 3
- Advanced Electronic Population Health and Personal Health Record Tools to Improve Once Lifetime Hepatitis C ScreeningCompletedNCT03654365Not applicable
- Terminator 2 RegisterStatus unknownNCT03643172
- The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver FailureStatus unknownNCT03640728
- The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate CapsulesCompletedNCT03638076Phase 2
- Plant Sterols and Plant Stanols and Liver InflammationStatus unknownNCT03627819Not applicable
- Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.CompletedNCT03627507Phase 2/3
- Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney TransplantWithdrawnNCT03623568Phase 4
- Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver CirrhosisCompletedNCT03620474Phase 1/2
- Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral TherapyCompletedNCT03612973Not applicable
- Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty LiverStatus unknownNCT03604016Phase 4
- Seroprevalence Hepatitis E Infection in Healthy Blood DonorsCompletedNCT03601221
- Tenofovir Combination or Mono-therapy for MDR CHBStatus unknownNCT03597633
- A Study in Healthy VolunteersCompletedNCT03596697Phase 1
- Phase II AutoImmune HepatitisWithdrawnNCT03593460Phase 2
- Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver DiseaseStatus unknownNCT03591783
- Prevalence of Hepatitis c Virus Infection Among Rheumatological PatientsCompletedNCT03587714
- Study on Gut Microbiota in Chronic HBV Infected PatientsStatus unknownNCT03587467
- APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis BCompletedNCT03585322Phase 1
- A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease RiskWithdrawnNCT03585101Phase 4
- Community Access, Retention in Care, and Engagement for Hepatitis C TreatmentCompletedNCT03581383Not applicable
- Simplified Antiviral Treatment Strategy for Hepatitis C in MyanmarCompletedNCT03579576
- Eight Weeks of Elbasvir/Grazoprevir in the Treatment of HCV Genotype 4CompletedNCT03578640Phase 3
- Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative TreatmentCompletedNCT03577938Not applicable
- Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnNCT03575208Phase 2
- Transmission of Chronic Hepatitis C in PregnancyCompletedNCT03570112
- A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding BiomarkersStatus unknownNCT03568578Not applicable
- Autoantibodies and Direct-acting AntiviralsCompletedNCT03566966
- Epidemiology of Chronic Hepatitis C and Disease ModellingCompletedNCT03566563
- Switching From Tenofovir Disoproxi Fumarate to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Antiviral ResistanceStatus unknownNCT03566030
- Examining Hepatitis C Reinfection Rates in KenyaCompletedNCT03564639
- Treatment Efficacy and Safety of TDF-TAF Switch Study in South KoreaStatus unknownNCT03559790
- Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 TrialStatus unknownNCT03551444Phase 3
- Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San DiegoStatus unknownNCT03551002
- Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution TherapyStatus unknownNCT03549312Phase 4
- The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B PatientsCompletedNCT03546530Not applicable